Literature DB >> 32402985

The association between midlife lipid levels and late-life brain amyloid deposition.

Erin E Bennett1, Kan Z Gianattasio2, Timothy M Hughes3, Thomas H Mosley4, Dean F Wong5, Rebecca F Gottesman6, Melinda C Power2.   

Abstract

Elevated low-density lipoprotein cholesterol and total cholesterol in midlife and decline in total cholesterol from mid- to late-life are associated with incident dementia. Whether brain amyloid deposition mediates this relationship is unclear. We explored the association between midlife blood lipid levels and mid- to late-life change in lipid levels with brain amyloid deposition assessed using florbetapir PET scans in a biracial sample of 325 nondemented participants of the Atherosclerosis Risk in Communities-PET Amyloid Imaging study. Midlife total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and triglycerides were not significantly associated with late-life amyloid burden after adjusting for covariates. Associations between changes in lipids and late-life amyloid deposition were similarly null. Lipids may contribute to dementia risk through alternate mechanisms.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer’s disease; Amyloid; Epidemiology; Lipids

Mesh:

Substances:

Year:  2020        PMID: 32402985      PMCID: PMC7340169          DOI: 10.1016/j.neurobiolaging.2020.03.015

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  2 in total

1.  Association Between Midlife Vascular Risk Factors and Estimated Brain Amyloid Deposition.

Authors:  Rebecca F Gottesman; Andrea L C Schneider; Yun Zhou; Josef Coresh; Edward Green; Naresh Gupta; David S Knopman; Akiva Mintz; Arman Rahmim; A Richey Sharrett; Lynne E Wagenknecht; Dean F Wong; Thomas H Mosley
Journal:  JAMA       Date:  2017-04-11       Impact factor: 56.272

2.  Increased midlife triglycerides predict brain β-amyloid and tau pathology 20 years later.

Authors:  Katarina Nägga; Anna-Märta Gustavsson; Erik Stomrud; Daniel Lindqvist; Danielle van Westen; Kaj Blennow; Henrik Zetterberg; Olle Melander; Oskar Hansson
Journal:  Neurology       Date:  2017-12-01       Impact factor: 9.910

  2 in total
  2 in total

1.  Metabolic syndrome and its components in relation to in vivo brain amyloid and neurodegeneration in late middle age.

Authors:  Priya Palta; Brady Rippon; Mouna Tahmi; Greysi Sherwood; Luisa Soto; Fernando Ceballos; Krystal Laing; Hengda He; Christiane Reitz; Qolamreza Razlighi; Jeanne A Teresi; Herman Moreno; Adam M Brickman; José A Luchsinger
Journal:  Neurobiol Aging       Date:  2020-10-14       Impact factor: 4.673

Review 2.  Cholesterol as a key player in amyloid β-mediated toxicity in Alzheimer's disease.

Authors:  Vladimir Rudajev; Jiri Novotny
Journal:  Front Mol Neurosci       Date:  2022-08-25       Impact factor: 6.261

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.